ifetroban
ifetroban: developed by 1 company · 2 clinical trials tracked.
ifetroban evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
How could ifetroban → CPIX affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence4 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (3)
| Company | Phase |
|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) cardiomyopathy associated with Duchenne muscular dystrophy (… | Phase 2 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) Idiopathic Pulmonary Fibrosis; Duchenne Muscular Dystrophy C… | Phase 2 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) Systemic Sclerosis (SSc) | Phase 2 |
Clinical Trials (2)
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Determine the Safety and Efficacy of Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Primary endpoint: Change from baseline in Forced Vital Capacity (FVC) in mL
A Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study With an Open-Label Extension to Determine the Safety, Pharmacokinetics and Efficacy of Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
Primary endpoint: Incidence of Treatment-Emergent Adverse Events
Frequently asked questions
Who is developing ifetroban?
ifetroban is being developed by CUMBERLAND PHARMACEUTICALS INC.
How many clinical trials involve ifetroban?
BioSniper tracks 2 clinical trials involving ifetroban.